Cytomegalovirus resistance in transplant patients Review
<p>CMV is a major cause of disease and mortality in patients undergoing Solid Organ Transplants (SOT) and Hematopoietic Stem Cell Transplants (HSCT). In SOT, CMV infection usually establishes itself in the first three months after transplantation in patients who do not receive prophylaxis.<...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
Global Journal of Clinical Virology - Peertechz Publications,
2023-10-19.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | peertech__10_17352_gjcv_000013 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a David Tarragó |e author |
| 245 | 0 | 0 | |a Cytomegalovirus resistance in transplant patients Review |
| 260 | |b Global Journal of Clinical Virology - Peertechz Publications, |c 2023-10-19. | ||
| 520 | |a <p>CMV is a major cause of disease and mortality in patients undergoing Solid Organ Transplants (SOT) and Hematopoietic Stem Cell Transplants (HSCT). In SOT, CMV infection usually establishes itself in the first three months after transplantation in patients who do not receive prophylaxis.</p> | ||
| 540 | |a Copyright © David Tarragó et al. | ||
| 546 | |a en | ||
| 655 | 7 | |a Review Article |2 local | |
| 856 | 4 | 1 | |u https://doi.org/10.17352/gjcv.000013 |z Connect to this object online. |